Cargando…
Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient
BACKGROUND: Chronic rhinosinusitis (CRS) affects 14% of the general population. The Sino-Nasal Outcome Test 22 (SNOT-22) is a reliable instrument assessing the impact of CRS. This study aimed to examine the reliability and construct validity of the translated Bahasa Malaysia version of SNOT-22. METH...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Penerbit Universiti Sains Malaysia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036927/ https://www.ncbi.nlm.nih.gov/pubmed/35528810 http://dx.doi.org/10.21315/mjms2022.29.2.12 |
_version_ | 1784693621598978048 |
---|---|
author | RAMIZA RAMZA, Ramli SHIFA, Zulkifli BAHARUDIN, Abdullah SAKINAH, Mohamad NORASNIEDA, Md Shukri |
author_facet | RAMIZA RAMZA, Ramli SHIFA, Zulkifli BAHARUDIN, Abdullah SAKINAH, Mohamad NORASNIEDA, Md Shukri |
author_sort | RAMIZA RAMZA, Ramli |
collection | PubMed |
description | BACKGROUND: Chronic rhinosinusitis (CRS) affects 14% of the general population. The Sino-Nasal Outcome Test 22 (SNOT-22) is a reliable instrument assessing the impact of CRS. This study aimed to examine the reliability and construct validity of the translated Bahasa Malaysia version of SNOT-22. METHODS: This cross-sectional study was conducted in the Otorhinolaryngology clinic in Universiti Sains Malaysia (USM). Seventy CRS respondents and 39 healthy participants were included. The Bahasa Malaysia translated SNOT-22 (bmSNOT-22) was produced using rigorous forward and backward translation. Statistical analyses used included feasibility, Cronbach’s alpha, intraclass correlation coefficient, Pearson’s correlation coefficient and factor analysis. RESULTS: The feasibility was 97.2% in the initial test and 100% in the retest. The Cronbach’s alpha was 0.89 in the initial test. The average intraclass correlation coefficient (ICC) was 0.90, indicating good test-retest reliability. The bmSNOT-22 discriminated between the control group and patients (t = 15.33; P < 0.001). CONCLUSION: The bmSNOT-22 is reliable, and validity established therefore recommended for Malaysia’s clinicians and researchers as a measurement tool for the outcome in sino-nasal disorders such as rhinosinusitis and nasal polyps. |
format | Online Article Text |
id | pubmed-9036927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Penerbit Universiti Sains Malaysia |
record_format | MEDLINE/PubMed |
spelling | pubmed-90369272022-05-05 Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient RAMIZA RAMZA, Ramli SHIFA, Zulkifli BAHARUDIN, Abdullah SAKINAH, Mohamad NORASNIEDA, Md Shukri Malays J Med Sci Original Article BACKGROUND: Chronic rhinosinusitis (CRS) affects 14% of the general population. The Sino-Nasal Outcome Test 22 (SNOT-22) is a reliable instrument assessing the impact of CRS. This study aimed to examine the reliability and construct validity of the translated Bahasa Malaysia version of SNOT-22. METHODS: This cross-sectional study was conducted in the Otorhinolaryngology clinic in Universiti Sains Malaysia (USM). Seventy CRS respondents and 39 healthy participants were included. The Bahasa Malaysia translated SNOT-22 (bmSNOT-22) was produced using rigorous forward and backward translation. Statistical analyses used included feasibility, Cronbach’s alpha, intraclass correlation coefficient, Pearson’s correlation coefficient and factor analysis. RESULTS: The feasibility was 97.2% in the initial test and 100% in the retest. The Cronbach’s alpha was 0.89 in the initial test. The average intraclass correlation coefficient (ICC) was 0.90, indicating good test-retest reliability. The bmSNOT-22 discriminated between the control group and patients (t = 15.33; P < 0.001). CONCLUSION: The bmSNOT-22 is reliable, and validity established therefore recommended for Malaysia’s clinicians and researchers as a measurement tool for the outcome in sino-nasal disorders such as rhinosinusitis and nasal polyps. Penerbit Universiti Sains Malaysia 2022-04 2022-04-21 /pmc/articles/PMC9036927/ /pubmed/35528810 http://dx.doi.org/10.21315/mjms2022.29.2.12 Text en © Penerbit Universiti Sains Malaysia, 2022 https://creativecommons.org/licenses/by/4.0/This work is licensed under the terms of the Creative Commons Attribution (CC BY) (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Original Article RAMIZA RAMZA, Ramli SHIFA, Zulkifli BAHARUDIN, Abdullah SAKINAH, Mohamad NORASNIEDA, Md Shukri Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient |
title | Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient |
title_full | Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient |
title_fullStr | Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient |
title_full_unstemmed | Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient |
title_short | Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient |
title_sort | validity and reliability study of bahasa malaysia version of sino-nasal outcome test 22 in chronic rhinosinusitis patient |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036927/ https://www.ncbi.nlm.nih.gov/pubmed/35528810 http://dx.doi.org/10.21315/mjms2022.29.2.12 |
work_keys_str_mv | AT ramizaramzaramli validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient AT shifazulkifli validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient AT baharudinabdullah validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient AT sakinahmohamad validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient AT norasniedamdshukri validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient |